VESIZEN

This brand name is authorized in Nigeria.

Active ingredients

The drug VESIZEN contains one active pharmaceutical ingredient (API):

1	Solifenacin UNII KKA5DLD701 - SOLIFENACIN SUCCINATE
	Solifenacin is a competitive, specific cholinergic-receptor antagonist. In vitro and in vivo pharmacological studies indicate that solifenacin is a competitive inhibitor of the muscarinic M3 subtype receptor.
	Read more about Solifenacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-8259	Film coated tablet	Vesizen Tablets 5mg TAB_FILM_COATED 5 mg 3 X 10packs	19 RNW-PP-263941 Vesizen Tablets 5mg SOLIFENACIN SUCCINATE TABLETS Each film coated tablet contains: Solifenacin Succinate 5mg, Anhydrous Lactose, Hypromellose, Corn Starch, Magnesium Stearate, Opadry White, Ferric Oxide, Purified Water B4-8259 Drugs Imported Products 310packs POM 2 5/20/2022 RANBAXY NIGERIA LIMITED, ABIMBOLA STREET, ILASAMAJA, ISOLO, LAGOS 17932744 rosanna.iwuala@sunpharma.com SUN PHARMACEUTICAL INDUSTRIES LTD (INDIA), SEZ Unit - I, Plot No. A-41, Industrial Area, Phase VIIIA, S.A.S Nagar, Mohali - 160071, Punjab, India , India	31/10/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04BD08	Solifenacin	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-8259